1. Market Research
  2. > Healthcare Market Trends
  3. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Argentina

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Argentina
ARGENTINA1
HEALTHCARE SYSTEM1
Facts and Figures 1
Market Indicators2
Provision and Funding 4
New Universal Health Insurance System 4
Current Healthcare System 4
PAMI 5
Policy, Regulation, and Funding7
PRICING7
Prescription Drugs7
Generic Drugs 7
Hospital Drugs7
Tenders7
Direct Negotiations 8
OTC Drugs 8
REIMBURSEMENT 8
Admission to Reimbursement 8
PMOE Formulary8
Individual Formularies 9
Non-PMOE Drugs10
High-cost Drugs10
Public Sector Formularies 10
Reimbursement Categories 11
PMOE Formulary Drugs 11
Non-PMOE Formulary Drugs 12
Redistribution Fund for High-cost Drugs 12
Public Sector Patients 13
Reimbursement Prices13
Manufacturer/Pharmacy Subsidies13
Reference Prices 13
Hospital Reimbursement13
Formularies13
Funding14
Changes in Reimbursement Status 15
PMOE Formulary15
Individual Formularies 15
Changes in Reimbursement Prices 15
Price Controls 15
Price Caps 16
PAMI 17
Discounts 17
PHARMACOECONOMICS17
Pharmacoeconomic Requirements17
Argentina, Pharmaceutical Pricing and Reimbursement Concise Guide
v
PMOE 17
PAMI 18
SUR 18
PRICE BUILD UP 18
Wholesalers 18
Margins 18
Background18
Retail Pharmacies19
Margins 19
Background19
OTC Sales 19
E-Pharmacy 20
Dispensing Doctors 20
Sales Tax 20
COST CONTAINMENT 20
Industry Paybacks20
Promotional Costs20
Patient Co-payments21
Insured Patients21
Uninsured Patients 22
Prescribing Controls22
Generics22
Bioequivalence 23
Intellectual Property23
INN Prescribing and Generic Substitution23
Rx-to-OTC Switches 23
OTC Market 24
Parallel Trade24
Counterfeiting 24
FUTURE DEVELOPMENTS 25
Outlook25
Universal Health Insurance System 25
Price Protection Programme 25
Health Technology Assessment26
NAMES and ADDRESSES 26

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

U.S. Infectious Diseases in Hospitals, Labs, Blood Banks and POC/Point-of-Care Locations

U.S. Infectious Diseases in Hospitals, Labs, Blood Banks and POC/Point-of-Care Locations

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack  (test volumes, sales forecasts, supplier shares) $7,500. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.